AzTrials
AzTrials

Developmental Language DisordersNCT04253600

Understanding the Predictive Factors and the Neurocognitive Basis of Developmental Language Disorder

A study testing Risk profile screening questionnaire, Investigation of the neural correlates of DLD using Magnetic Resonance Imagery (MRI) and Online investigation of predictive factors associated with DLD and LANCOM app development in people with Developmental Language Disorders and Language Development, run by Université Catholique de Louvain at 2 sites in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

For most children, language acquisition might appear like an effortless phenomenon, mostly arising from informal daily interaction with their surrounding people. Despite an adequate learning environment however, some children encounter major difficulties in learning their native tongue and develop a Developmental… Read more about this study

Who is it for?
Ages Up to 18 monthsHealthy volunteers can take part
What is being tested?
Risk profile screening questionnaire, Investigation of the neural correlates of DLD using Magnetic Resonance Imagery (MRI) and Online investigation of predictive factors associated with DLD and LANCOM app development
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,500 participants
Where
2 sitesBelgium
Study dates
1 Apr 2020to 31 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 18 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Having a child, preferably aged from 0 to 12 months, and a maximum of 18 months at the time of recruitment
  • Having French as (one of) mother tongue(s)

Who cannot join

  • Severe sensory deprivation resulting in hearing and/or visual impairment (i.e., deafness, blindness) detected at birth
  • Chromosomal abnormalities (e.g., Down syndrome, Turner syndrome, Williams syndrome)
  • Phenylketonuria
  • Cleft lips or palates

Trial locations and contacts

2 sites in 1 country.

Jolijn Vanderauwera, Prof. contact

+32470503454

jolijn.vanderauwera@uclouvain.be

Belgium2 sites
  • Institut de recherche en sciences psychologiques (IPSY, UCLouvain)

    Louvain-la-Neuve, 1348

    Jolijn Vanderauwera, Prof., +32470503454, jolijn.vanderauwera@uclouvain.be

    Camille Bonnet, +32494172731, camille.bonnet@uclouvain.be

  • Institute of NeuroScience (IoNS, UCLouvain)

    Woluwe-Saint-Lambert, 1200

    Jolijn Vanderauwera, Prof., +32470503454, jolijn.vanderauwera@uclouvain.be

    Camille Bonnet, +32494172731, camille.bonnet@uclouvain.be

Other trials in Belgium

About this study

Official title: Understanding the Predictive Factors and the Neurocognitive Basis of Developmental Language Disorder Original Public Title (French) : Projet ELENA, Etude Sur le développement du Langage Chez l'ENfAnt. Public Title (English) : Study on Infants' Language Development

For most children, language acquisition might appear like an effortless phenomenon, mostly arising from informal daily interaction with their surrounding people. Despite an adequate learning environment however, some children encounter major difficulties in learning their native tongue and develop a Developmental Language Disorder (DLD). Although the existence of a multi-factorial etiology has seemed to reach an agreement, presumably combining genetic and environmental factors to some kind of neural disruption, the underlying mechanisms leading to DLD are, to date, poorly understood.

Many studies have attempted to identify risk factors and early predictors associated with the future development of a language impairment. However, despite the constant efforts to identify early markers able to differentiate between transient and persistent language difficulties, early detection of children who will be developing a DLD remains highly difficult, partially due to the lack of direct and ecological measures of early language and communication development. In addition research on the causal neural correlates of DLD is in its infancy, and often compromised by small sample sizes or analyses methods that lack anatomical specificity to determine the neural correlates of language impairment.

Hence, In order to improve early detection and, therefore, language intervention, this longitudinal research project aims at investigating the early predictive factors as well as the neurocognitive basis of DLD by means of an integrative, multi-dimensional, and multi-methodological approach. To substantially gain insight, this research ideally integrates risk factors at multiple different levels, including the cognitive, neurobiological, parental and environmental level. From a methodological perspective, we will combine direct and indirect behavioral methods with neuroimaging methods in order to propose an early predictive model of language development.

Read the detailed description

The present research project can be divided into four main data collection steps. The first step concerns families' recruitment through a principle of population-based screening. Parents and/or caregivers of children aged from 0 to 18 months will be asked to complete a screening questionnaire that aims to evaluate families' general risk profile associated with the development of DLD. A subsample of at-risk and control families will be selected based on the screening phase for longitudinal follow-up. The second step consists of the investigation of the neural correlates of DLD by using a natural-sleep MRI protocol in infants of 6 to 12 months old. The third step concerns the evaluation of predictive factors leading to DLD using indirect measures based on digital assessment of language development, parental and environmental characteristics (i.e., parents will have to fill in online questionnaires every 6 months during a 3-year timeframe). This step will also be dedicated to the development of an application that aims at evaluating early development of language and communication (i.e., LANCOM app). Finally, the fourth step comprises additional in-depth investigation of DLD's predictive factors, by means of direct measures, including individual cognitive and behavioral assessment, as well as an automated analysis of the child's language environment using the Language ENvironment Analysis digital language processor recording device (LENA®). Data collection for this last step will take place once a year over the whole project's timeframe.

Being tested
Risk profile screening questionnaire, Investigation of the neural correlates of DLD using Magnetic Resonance Imagery (MRI), Online investigation of predictive factors associated with DLD and LANCOM app development, Individual behavioral and cognitive assessment, Automated analysis of language development and environment
Keywords
Developmental Language Disorders, Predictive factors, Neural correlates, Neurocognitive basis, Language development, Natural-sleep MRI protocol
Medical subject headings
Language Development Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Risk profile screening questionnaireBehavioural

    Families will be asked to complete a LimeSurvey questionnaire that aims at evaluating general risk profiles associated with DLD (e.g., no elevated risk, behavioral risk, environmental risk, familial risk), as well as our exclusion criteria (e.g., hearing deficit).

  • Investigation of the neural correlates of DLD using Magnetic Resonance Imagery (MRI)Procedure or surgery

    MRI data acquisition will take place during natural sleep in infants aged from 6 to 12 months. First, families will have to complete a security questionnaire to make sure that neither the children nor the accompanying parent have any known contraindication preventing the MRI session and that none of them is wearing any ferro-magnetic elements. Then, families will be welcomed in a calm and child-friendly environment where we will propose them some preparatory games known to facilitate sleep in children. MRI protocol will comprise structural and functional images and won't exceed 30 minutes.

  • Online investigation of predictive factors associated with DLD and LANCOM app developmentBehavioural

    Parents will be asked to complete a series of online questionnaires every six months. Questionnaires will be created on LimeSurvey and will include different questionnaires, scales, and observations that aim at evaluating children's development, and especially language development, as well as parental and environmental characteristics.

  • Individual behavioral and cognitive assessmentBehavioural

    Individual cognitive and behavioral assessment will be scheduled once a year, around the child's birth date, and will comprise an extensive battery of standardized evaluation appropriate for the child's age. This individual evaluation will focus on several developmental aspects including language, psychomotor, behavioral and cognitive development, as well as executive and socio-emotional functioning, depending on the age of the children. Evaluations will be adapted to each child's specific profile, while respecting the following administration rules: (1) we will prioritize language development testing, (2) testing sessions will be adapted to each child's pace and possibilities, (3) if a child does not want to take part in the assessment, feels tired, or does not seem to be comfortable with the investigator, tests won't be administered.

  • Automated analysis of language development and environmentBehavioural

    Following the individual assessment, families will be asked to record their child's language environment over a 2-days' timeframe using the LENA® device, a "small wearable device allowing for large-scale all-day audio recording and automated vocal analyses of speech segments". An automatic analysis of the recordings, performed by the LENA pro software algorithms, will provide amongst others, a direct and natural measure of the child's number of vocalizations, adult word counts, conversational turns, duration of exposure to electronic media versus to meaningful language. Data acquisition will take place once a year following our sample selection, with a required recording time per day ranging from 12 to 16 hours.

Study groups in NCT04253600
Study groupRoleWhat they receive
MRI AcquisitionOtherThis does not refer to any group intervention. At-risk and control children will take part in a natural-sleep MRI protocol.
Receives: Behavioral: Risk profile screening questionnaire; Procedure: Investigation of the neural correlates of DLD using Magnetic Resonance Imagery (MRI); Behavioral: Online investigation of predictive factors associated with DLD and LANCOM app development; Behavioral: Individual behavioral and cognitive assessment; Behavioral: Automated analysis of language development and environment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Environmental characteristics

    Online questionnaires to be completed by parents and evaluating environmental characteristics of the child.

    Measured: From 6 months to 48 months of age

  2. Parental characteristics

    Online questionnaires to be completed by parents and evaluating parental characteristics of the child.

    Measured: From 6 months to 48 months of age

  3. Children's behavioral characteristics (indirect measure)

    Online questionnaires to be completed by parents, which aims at evaluating children's development, and in particular, their language development.

    Measured: From 6 months to 48 months of age

  4. Cognitive and behavioral characteristics (direct measure) as assessed by standardized batteries of tests

    Individual cognitive and behavioral assessment evaluating several developmental aspects including language, psychomotor, behavioral and cognitive development, as well as executive and socio-emotional functioning (e.g., EVALObb, EVALO2-6, WPPSI-IV). We will use batteries of neuropsychological standardized evaluation appropriate for the child's age.

    Measured: From 1 year to 4 years of age

  5. Evaluation of children's language development and environment using the Language ENvironment Analysis digital language processor recording device (LENA)

    Automated analysis of language development and environment using the LENA device. An automatic analysis of the recordings, performed by the LENA pro software algorithms, will provide amongst others, a direct and natural measure of the child's number of vocalizations, adult word counts, conversational turns, duration of exposure to electronic media versus to meaningful language.

    Measured: From 1 year to 4 years of age

  6. Magnetic Resonance Imagery analyses

    Evaluation of neural correlates of DLD using structural (and functional) images. Children aged from 6 months to 12(-18) months will be scanned only once.

    Measured: 6-12 months old

Secondary outcomes (1)
  1. Risk profiles analysis based on risk screening online questionnaire

    Evaluation of different risk profiles associated with the development of DLD (e.g., family risk, environmental risk) based on a risk screening online questionnaire to be completed by the parents.

    Measured: 0-18 months old (at screening)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2020
  2. Study start1 Apr 2020 (estimated)
  3. Primary completion1 Aug 2022 (estimated)
  4. Study completion31 Aug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
1,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04253600
Sponsor's protocol ID
ELENA
Status last verified
Jan 2020
First submitted
21 Jan 2020
Last updated
5 Feb 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: As part of the evaluation of neural correlates, participants have to indicate in the inform consent form, whether they allow the research team to share their data with other researchers or not. Only anonymized MRI data are susceptible to be shared with other researchers if families explicitly mentioned it on inform consent.

Questions about this trial

What is this clinical trial studying?

A study testing Risk profile screening questionnaire, Investigation of the neural correlates of DLD using Magnetic Resonance Imagery (MRI) and Online investigation of predictive factors associated with DLD and LANCOM app development in people with Developmental Language Disorders and Language Development, run by Université Catholique de Louvain at 2 sites in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jolijn Vanderauwera, Prof. (+32470503454, jolijn.vanderauwera@uclouvain.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Environmental characteristics (time frame: From 6 months to 48 months of age). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in